北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (6): 1022-1026. doi: 10.19723/j.issn.1671-167X.2018.06.014

• 论著 • 上一篇    下一篇

抗中性粒细胞胞质抗体相关性血管炎的病情评估方法及其相关性

李胜光1,(),张清2,周惠琼2   

  1. 1. 北京大学国际医院风湿免疫科, 北京 102206
    2. 中国人民解放军总医院第四医学中心风湿科, 北京 100048
  • 收稿日期:2018-07-09 出版日期:2018-12-18 发布日期:2018-12-18
  • 通讯作者: 李胜光 E-mail:lishengguang@vip.sina.com

Comparison of disease activities and extent measurements for anti-neutrophil cytoplasmic autoantibody-associated vasculitis

Sheng-guang LI1,(),Qing ZHANG2,Hui-qiong ZHOU2   

  1. 1. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing 102206, China
    2. Department of Rheumatology, Fouth Medical Center of PLA General Hospital, Beijing 100048, China
  • Received:2018-07-09 Online:2018-12-18 Published:2018-12-18
  • Contact: Sheng-guang LI E-mail:lishengguang@vip.sina.com

摘要:

目的: 探讨抗中性粒细胞胞质抗体相关性血管炎(anti-neutrophil cytoplasmic antibodies-associated vasculitis,AAV)病情评估方法的意义及其各自的相关性。方法: 以121例来自北京大学国际医院和中国人民解放军总医院第四医学中心住院确诊的AAV患者为研究对象,包括嗜酸性肉芽肿性多血管炎(eosinophilic granulomatous with polyangiitis,EGPA)15例、肉芽肿性多血管炎(granulomatous with polyangiitis,GPA)59例及显微镜下多血管炎(microscopic polyangiitis,MPA)47例。依据随访中是否死亡,将其分为死亡组和生存组,分别应用伯明翰系统性血管炎活动评分(Birmingham vasculitis activity score,BVAS)-1994、BVAS-2003、BVAS/GPA、血管炎损伤指数(vasculitis damage index,VDI)、疾病范围指数(disease extent index,DEI)、5因子评估量表(five factor score,FFS)-1996及FFS-2009共7种病情评价量表进行评分,比较两组间各指标的相关性。结果: 死亡组患者各项评估指标(BVAS、VDI、DEI及FFS)得分均明显高于生存组(P<0.05),且EGPA患者无论在疾病活动度(BVAS 1994/2003)、器官受累情况(VDI/DEI)还是疾病预测因子(FFS 1996/2009)评分方面均低于GPA、MPA和总AAV患者。其中BVAS-2003与BVAS-1994、BVAS/GPA之间具有高度相关性(r值分别为0.9和0.7),BVAS-1994与BVAS/GPA之间呈一般性相关(r=0.69);FFS-1996与FFS-2009之间具有高度相关性(r=0.73);DEI与BVAS-1994、BVAS-2003及BVAS/GPA之间均呈一般性相关(r值分别为0.62、0.65和0.62),VDI与BVAS-1994和BVAS-2003之间亦呈一般性相关(r值分别为0.49和0.52)。结论: AAV各评估指标均可作为评测疾病活动性及判断预后的指标,其中BVAS-2003与BVAS-1994及BVAS/GPA之间,FFS-1996与FFS-2009之间均呈高度相关性。

关键词: 抗中性粒细胞胞质抗体相关性血管炎, 预后, 疾病活动性

Abstract:

Objective: To investigate the significance of a set of seven disease activities and extension measurements and their correlations between one and another for anti-neutrophil cytoplasmic autoantibody associated vasculitis (AAV).Methods:A total of 121 patients from Peking University International Hospital and Fouth Medical Center of PLA General Hospital with confirmed diagnoses of AAV clinically were enrolled in the study, including 15 cases of eosinophilic granulomatous with polyangiitis (EGPA), 59 cases of granulomatous with polyangiitis (GPA) and 47 cases of microscopic polyangiitis (MPA). A hundred and twenty-one AAV patients were divided into death group and survival group according to their survival conditions. A set of seven disease assessment scales including Birmingham vasculitis activity score (BVAS)-1994, BVAS-2003, as well as BVAS/GPA, vasculitis damage index (VDI), disease extent index (DEI), five factor score (FFS)-1996, and FFS-2009 were measured and scored one by one, and their relationships which were represented by Spearman correlation coefficient were compared between one and another.Results:BVAS-1994, BVAS-2003, as well as BVAS/GPA, VDI, DEI, and FFS, all of those seven evaluation indexes of the AAV patients in the death group were significantly higher than those in the survival group (P<0.05). Except for BVAS/GPA, all those above indicators in the patients with EGPA were lower than those in the patients with GPA and those in the patients with MPA, and those in all of the AAV patients as a whole group. There were high correlations among BVAS-2003, BVAS-1994 and BVAS/GPA (r values were 0.9 and 0.7, respectively); BVAS-1994 was fairly correlated with BVAS/GPA (r=0.69); FFS-1996 and FFS-2009 were highly correlated (r=0.73) with each other; BVAS-1994, BVAS-2003 and BVAS/GPA were fairly correlated with DEI (with r values of 0.62, 0.65, and 0.62, respectively); VDI was also fairly correlated with BVAS-1994 and with BVAS-2003 (r values were 0.49 and 0.52, respectively).Conclusion:All of those seven AAV assessment indicators above can be used as indicators of disease activity and prognosis in AAV patients, most of which were relevant within one and another. There were high correlations among BVAS-2003, BVAS-1994 and BVAS/GPA, and besides, there were also high correlations between FFS-1996 and FFS-2009.

Key words: Anti-neutrophil cytoplasmic antibody-associated vasculitis, Prognosis, Disease activities

中图分类号: 

  • R593.9

表1

AAV各种评估量表在AAV及其分型中的得分(x-±s)"

Items EGPA (n=15) MPA (n=47) GPA (n=59) AAV (n=121)
BVAS-1994 16.2±8.4 23.5±6.0* 23.3±9.4* 22.5±8.4*
BVAS-2003 16.9±7.7 22.4±6.8* 22.8±9.8* 21.9±8.6*
VDI 3.1±2.5 4.2±2.5 4.0±2.4 4.0±2.5
DEI 8.2±3.1 7.8±2.8 8.9±3.2 8.4±3.0
FFS-1996 0.1±0.4 1.5±1.1* 0.9±1.0* 1.0±1.1*#
FFS-2009 0.1±0.4 1.4±0.9* 1.0±1.0*# 1.1±1.0*#

表2

AAV生存组和死亡组7种疾病评估量表得分比较"

Items Death group (n=25) Survival group (n=96) t P
Age/years 69±11 60±16 2.8 0.006
BVAS-1994 26.2±7.5 21.0±8.5 2.8 0.006
BVAS-2003 26.9±8.3 20.0±8.8 3.5 0.001
BVAS/GPA 8.3±4.9 5.9±2.9 2.2 0.031
VDI 5.8±2.4 3.5±2.2 4.6 <0.001
DEI 9.5±3.5 8.0±2.8 2.2 0.028
FFS-1996 1.5±1.2 0.9±1.0 2.7 0.008
FFS-2009 1.8±1.1 0.9±0.9 4.0 <0.001

表3

7种AAV疾病评估量表间的Spearman相关系数"

Items BVAS-1994 BVAS-2003 BVAS/GPA VDI DEI FFS-1996 FFS-2009
BVAS-1994 1
BVAS-2003 0.90* 1
BVAS/GPA 0.69* 0.70* 1
VDI 0.49* 0.52* 0.37* 1
DEI 0.62* 0.65* 0.62* 0.37* 1
FFS-1996 0.44* 0.45* 0.23 0.31* 0.30* 1
FFS-2009 0.38* 0.39* 0.09 0.28* 0.23# 0.73* 1
[1] Jennette JC, Falk RJ, Bacon PA , et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides[J]. Arthritis Rheum, 2013,65(1):1-11.
doi: 10.1002/art.37715 pmid: 23045170
[2] Yates M, Watts RA, Bajema IM , et al. EULAR/ERA-EDTA re-commendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016,75(9):1583-1594.
[3] Lanham JG, Elkon KB, Pusey CD , et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome[J]. Medicine, 1984,63(2):65-81.
doi: 10.1097/00005792-198403000-00001
[4] Masi AT, Hunder GG, Lie JT , et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)[J]. Arthritis Rheum, 1990,33(8):1094-1100.
doi: 10.1002/art.1780330806 pmid: 2202307
[5] Leavitt RY, Fauci AS, Bloch DA , et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis[J]. Arthritis Rheum, 1990,33(8):1101-1107.
[6] Watts R, Lane S, Hanslik T , et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiolo-gical studies[J]. Ann Rheum Dis, 2007,66(2):222-227.
[7] Luqmani RA, Bacon PA, Moots RJ , et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis[J]. QJM, 1994,87(11):671.
[8] Eisenberger U, Fakhouri F, Vanhille P , et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome[J]. Nephrol Dial Transplant, 2005,20(7):1392-1399.
doi: 10.1093/ndt/gfh830
[9] Stone JH, Hoffman GS, Merkel PA , et al. A disease-specific activity index for Wegener’s granulomatosis: modification of the Birmingham vasculitis activity score[J]. Arthritis Rheum, 2001,44(4):912-920.
doi: 10.1002/(ISSN)1529-0131
[10] Exley AR, Bacon PA, Luqmani RA , et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides[J]. Arthritis Rheum, 2014,40(2):371-380.
doi: 10.1002/art.1780400222 pmid: 9041949
[11] De GK, Gross WL, Herlyn K , et al. Development and validation of a disease extent index for Wegener’s granulomatosis[J]. Clin Nephrol, 2001,55(1):31-38.
pmid: 11200865
[12] Guillevin L, Lhote F, Gayraud M , et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients[J]. Medicine, 1996,75(1):17-28.
doi: 10.1097/00005792-199601000-00003
[13] Guillevin L, Pagnoux C, Seror R , et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort[J]. 2011,90(1):19-27.
doi: 10.1097/MD.0b013e318205a4c6 pmid: 21200183
[14] Moiseev S, Novikov P, Jayne D , et al. End-stage renal disease in ANCA-associated vasculitis[J]. Nephrol Dial Transplant, 2017,32(2):248-253.
doi: 10.1093/ndt/gfw046 pmid: 27190338
[15] Greenan K, Vassallo D, Chinnadurai R , et al. Respiratory manifestations of ANCA-associated vasculitis[J]. Clin Respir J, 2018,12(1):57-61.
doi: 10.1111/crj.12478 pmid: 27059787
[16] Frausova D, Hruskova Z, Lanska V , et al. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study[J]. Arthritis Res Ther, 2016(18):168.
doi: 10.1186/s13075-016-1055-5 pmid: 4944267
[17] 张清, 周惠琼, 郭娟 , 等. 抗中性粒细胞胞质抗体相关性血管炎死亡危险因素的探讨[J]. 中华医学杂志, 2017,97(43):3392-3395.
[1] 丁艳苓,沈宁,周庆涛,贺蓓,郑佳佳,赵心懋. 非免疫缺陷宿主念珠菌血流感染[J]. 北京大学学报(医学版), 2018, 50(6): 1063-1069.
[2] 唐兴国,颜野,邱敏,卢剑,陆敏,侯小飞,黄毅,马潞林. 单中心16年青年膀胱尿路上皮癌患者的诊治[J]. 北京大学学报(医学版), 2018, 50(4): 630-633.
[3] 朱冬冬,朱军,虞巍,王冰洁,陈宇珂,范宇,张中元,金杰,谌诚. 双侧睾丸肿瘤12例报道及文献回顾[J]. 北京大学学报(医学版), 2018, 50(4): 755-758.
[4] 李健男,冯芝恩,王琳,王衣祥,郭传瑸. 乏氧诱导因子-1α在口腔鳞状细胞癌颈淋巴转移中的作用[J]. 北京大学学报(医学版), 2018, 50(1): 26-32.
[5] 段文冰,宫立众,贾晋松,主鸿鹄,赵晓甦,江倩,赵婷,王婧,秦亚溱,黄晓军,江浩. 伴EVI1高表达的中高危急性髓系白血病临床特点及早期治疗效果[J]. 北京大学学报(医学版), 2017, 49(6): 990-995.
[6] 张铃福,侯纯升,郭丽梅,陶立元,凌晓锋,王立新,徐智,修典荣. 术中冰冻或术后石蜡病理报告T1b期胆囊癌的外科治疗策略[J]. 北京大学学报(医学版), 2017, 49(6): 1034-1037.
[7] 王惠, 叶锦棠, 姚红新, 李东, 董颖. 婴儿胚胎发育不良性神经上皮肿瘤1例报道并文献复习[J]. 北京大学学报(医学版), 2017, 49(5): 904-909.
[8] 关豹,曹振朋,彭鼎,李一帆,詹永豪,刘漓波,何世明,熊耕砚,李学松,周利群. T2N0M0期上尿路尿路上皮癌患者预后相关因素分析:单中心235例患者回顾性研究[J]. 北京大学学报(医学版), 2017, 49(4): 603-607.
[9] 陈杨,王艳荣,石燕,戴广海. 晚期结直肠癌患者一线应用FOLFOX方案化疗引起中性粒细胞减少的预后价值[J]. 北京大学学报(医学版), 2017, 49(4): 669-674.
[10] 李熠,徐莉,周彦恒,欧阳翔英,曹甜. 牙周正畸牙体联合治疗1例预后无望上前牙患者的长期疗效观察#br#[J]. 北京大学学报(医学版), 2017, 49(4): 740-744.
[11] 谢立簃,鲍旭辉,林晨,王征,张静,樊旼. Podoplanin在非小细胞肺癌中的表达[J]. 北京大学学报(医学版), 2017, 49(2): 357-360.
[12] 段鸿洲,张扬,李良,张家湧,伊志强,鲍圣德. 颅底手术中的三叉-心反射[J]. 北京大学学报(医学版), 2017, 49(1): 164-168.
[13] 邢云超,熊耕砚,方东,张争,蔡林,张雷,何志嵩,李学松,周利群. 上尿路尿路上皮癌术前预后相关因素分析及初步风险分层模型构建[J]. 北京大学学报(医学版), 2016, 48(6): 1032-1037.
[14] 刘瑾,熊耕砚,唐琦,方冬,李学松,周利群. 上尿路尿路上皮癌中RASSF1A基因启动子区域的甲基化状态及其临床意义[J]. 北京大学学报(医学版), 2016, 48(4): 571-578.
[15] 席晨光,范宇,杨新宇,刘漓波,王静华,胡帅,李妍妍,何群. 16例后肾腺瘤的临床病理特点及鉴别诊断[J]. 北京大学学报(医学版), 2016, 48(4): 598-602.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[5] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[6] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[7] 张安阳, 范田园. 运用响应曲面法优化核黄素磷酸钠海藻酸钙胃漂浮微球[J]. 北京大学学报(医学版), 2009, 41(6): 682 -686 .
[8] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[9] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[10] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .